|
1
|
McDonagh TA, Metra M, Adamo M, Gardner RS,
Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, et
al: 2021 ESC guidelines for the diagnosis and treatment of acute
and chronic heart failure. Eur Heart J. 42:3599–3726. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Levy D, Larson MG, Vasan RS, Kannel WB and
Ho KK: The progression from hypertension to congestive heart
failure. JAMA. 275:1557–1562. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martin TG, Juarros MA and Leinwand LA:
Regression of cardiac hypertrophy in health and disease: Mechanisms
and therapeutic potential. Nat Rev Cardiol. 20:347–363. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Katz AM and Rolett EL: Heart failure: When
form fails to follow function. Eur Heart J. 37:449–454. 2016.
View Article : Google Scholar
|
|
5
|
Dikic I: Proteasomal and autophagic
degradation systems. Annu Rev Biochem. 86:193–224. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu MM and Shu HB: Multifaceted roles of
TRIM38 in innate immune and inflammatory responses. Cell Mol
Immunol. 14:331–338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xue Q, Zhou Z, Lei X, Liu X, He B, Wang J
and Hung T: TRIM38 negatively regulates TLR3-mediated IFN-β
signaling by targeting TRIF for degradation. PLoS One.
7:e468252012. View Article : Google Scholar
|
|
8
|
Hu MM, Yang Q, Xie XQ, Liao CY, Lin H, Liu
TT, Yin L and Shu HB: Sumoylation promotes the stability of the DNA
sensor cGAS and the adaptor STING to regulate the kinetics of
response to DNA virus. Immunity. 45:555–569. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu Z, Hao C, Qian H, Zhao Y, Bo X, Yao Y,
Ma G and Chen L: Tripartite motif 38 attenuates cardiac fibrosis
after myocardial infarction by suppressing TAK1 activation via
TAB2/3 degradation. iScience. 25:1047802022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yao X, Dong R, Hu S, Liu Z, Cui J, Hu F,
Cheng X, Wang X, Ma T, Tian S, et al: Tripartite motif 38
alleviates the pathological process of NAFLD-NASH by promoting TAB2
degradation. J Lipid Res. 64:1003822023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pang Y, Ma M, Wang D, Li X and Jiang L:
TANK promotes pressure overload induced cardiac hypertrophy via
activating AKT signaling pathway. Front Cardiovasc Med.
8:6875402021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ehler E, Moore-Morris T and Lange S:
Isolation and culture of neonatal mouse cardiomyocytes. J Vis Exp.
6:501542013.
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
14
|
Cox J and Mann M: MaxQuant enables high
peptide identification rates, individualized p.p.b.-range mass
accuracies and proteome-wide protein quantification. Nat
Biotechnol. 26:1367–1372. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
UniProt Consortium: Uniprot: The universal
protein knowledgebase in 2023. Nucleic Acids Res. 51:D523–D531.
2023. View Article : Google Scholar :
|
|
16
|
Cantalapiedra CP, Hernández-Plaza A,
Letunic I, Bork P and Huerta-Cepas J: eggNOG-mapper v2: Functional
annotation, orthology assignments, and domain prediction at the
metagenomic scale. Mol Biol Evol. 38:5825–5829. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar :
|
|
18
|
Oka T, Akazawa H, Naito AT and Komuro I:
Angiogenesis and cardiac hypertrophy: Maintenance of cardiac
function and causative roles in heart failure. Circ Res.
114:565–571. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu X, Xu M, Geng M, Chen S, Little PJ, Xu
S and Weng J: Targeting protein modifications in metabolic
diseases: Molecular mechanisms and targeted therapies. Signal
Transduct Target Ther. 8:2202023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cockram PE, Kist M, Prakash S, Chen SH,
Wertz IE and Vucic D: Ubiquitination in the regulation of
inflammatory cell death and cancer. Cell Death Differ. 28:591–605.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qiu M, Chen J, Li X and Zhuang J:
Intersection of the ubiquitin-proteasome system with oxidative
stress in cardiovascular disease. Int J Mol Sci. 23:121972022.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu H, Zhou Z, Deng H, Tian Z, Wu Z, Liu
X, Ren Z and Jiang Z: Trim65 attenuates isoproterenol-induced
cardiac hypertrophy by promoting autophagy and ameliorating
mitochondrial dysfunction via the Jak1/Stat1 signaling pathway. Eur
J Pharmacol. 949:1757352023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu L, Jia M, Xiao L, Wang Z, Yao R, Zhang
Y and Gao L: TRIM-containing 44 aggravates cardiac hypertrophy via
TLR4/NOX4-induced ferroptosis. J Mol Med (Berl). 101:685–697. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee JM, Hammarén HM, Savitski MM and Baek
SH: Control of protein stability by post-translational
modifications. Nat Commun. 14:2012023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song L and Luo ZQ: Post-translational
regulation of ubiquitin signaling. J Cell Biol. 218:1776–1786.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu P, Cong X, Liao S, Jia X, Wang X, Dai
W, Zhai L, Zhao L, Ji J, Ni D, et al: Global identification of
phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and
an ERK-FBXO22-BAG3 axis in tumorigenesis. Cell Death Differ.
29:1–13. 2022. View Article : Google Scholar :
|
|
27
|
Zhu GW, Chen H, Liu SY, Lin PH, Lin CL and
Ye JX: PPM1B degradation mediated by TRIM25 ubiquitination
modulates cell cycle and promotes gastric cancer growth. Sci Rep.
15:61602025. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barbour H, Nkwe NS, Estavoyer B, Messmer
C, Gushul-Leclaire M, Villot R, Uriarte M, Boulay K, Hlayhel S,
Farhat B, et al: An inventory of crosstalk between ubiquitination
and other post-translational modifications in orchestrating
cellular processes. iScience. 26:1062762023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang L, Zhang X, Lin ZB, Yang PJ, Xu H,
Duan JL, Ruan B, Song P, Liu JJ, Yue ZS, et al: Tripartite motif 16
ameliorates nonalcoholic steatohepatitis by promoting the
degradation of phospho-TAK1. Cell Metab. 33:1372–1388.e7. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dorn GN II and Force T: Protein kinase
cascades in the regulation of cardiac hypertrophy. J Clin Invest.
115:527–537. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li L, Chen Y, Doan J, Murray J, Molkentin
JD and Liu Q: Transforming growth factor β-activated kinase 1
signaling pathway critically regulates myocardial survival and
remodeling. Circulation. 130:2162–2172. 2024. View Article : Google Scholar
|
|
32
|
Xie M, Zhang D, Dyck JR, Li Y, Zhang H,
Morishima M, Mann DL, Taffet GE, Baldini A, Khoury DS and Schneider
MD: A pivotal role for endogenous TGF-beta-activated kinase-1 in
the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc
Natl Acad Sci USA. 103:17378–17383. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hirata Y, Takahashi M, Morishita T,
Noguchi T and Matsuzawa A: Post-translational modifications of the
TAK1-TAB complex. Int J Mol Sci. 18:2052017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu YR and Lei CQ: TAK1-TABs complex: A
central signalosome in inflammatory responses. Front Immunol.
11:6089762021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu MM, Yang Q, Zhang J, Liu SM, Zhang Y,
Lin H, Huang ZF, Wang YY, Zhang XD, Zhong B and Shu HB: TRIM38
inhibits TNFα- and IL-1β-triggered NF-κB activation by mediating
lysosome-dependent degradation of TAB2/3. Proc Natl Acad Sci USA.
111:1509–1514. 2014. View Article : Google Scholar
|
|
36
|
Kim K, Kim JH, Kim I, Seong S and Kim N:
TRIM38 regulates NF-κB activation through TAB2 degradation in
osteoclast and osteoblast differentiation. Bone. 113:17–28. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Stelzer G, Rosen N, Plaschkes I, Zimmerman
S, Twik M, Fishilevich S, Stein TI, Nudel R, Lieder I, Mazor Y, et
al: The genecards suite: From gene data mining to disease genome
sequence analyses. Curr Protoc Bioinformatics. 54:1–30. 2016.
|
